Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective

Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective

Abstract Immunocompromised patients are disproportionately impacted by severe disease, hospitalization, and mortality associated with coronavirus disease 2019 (COVID-19). To optimize the management of these patients in clinical practice, we convened an expert panel to review current evidence on seve...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Loubet, Ilies Benotmane, Slim Fourati, Florent Malard, Fanny Vuotto, Elodie Blanchard, François Raffi, Stéphanie Nguyen, Nicolas de Prost, Jérôme Avouac
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-03-01
Series:Infectious Diseases and Therapy
Subjects:
Allogeneic hematopoietic stem cell transplantation
Chimeric antigen receptor (CAR) T cell therapy
COVID-19
Immunocompromised patients
Immunosuppressive therapy
Hematologic malignancy
Online Access:https://doi.org/10.1007/s40121-025-01124-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40121-025-01124-3

Similar Items